Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Giovanni, Pomponio"'
Autor:
Alessia Ferrarini, Angelo Vacca, Antonio Giovanni Solimando, Marcello Tavio, Rossella Acquaviva, Marco Rocchi, Cinzia Nitti, Aldo Salvi, Vincenzo Menditto, Michele Maria Luchetti Gentiloni, Alessandro Russo, Marco Moretti, Marianna Pavani, Andrea Giacometti, Martina Bonifazi, Lina Zuccatosta, Laura Romani, Vito Racanelli, Gianluca Moroncini, Armando Gabrielli, Giovanni Pomponio
Publikováno v:
European Journal of Clinical Investigation. 53
Controversies on sub-populations most sensitive to therapy and the best timing of starting the treatment still surround the use of immunomodulatory drugs in COVID-19.We designed a multicentre open-label randomised controlled trial to test the effect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b923742c46fe007a28733ee73bc9850
https://doi.org/10.1111/eci.13898
https://doi.org/10.1111/eci.13898
Autor:
Alain Kafyeke, Giovanni Pomponio, Andrea Balloni, Simona Gambini, Francesca Barbisan, Armando Gabrielli
Publikováno v:
Italian Journal of Medicine, Vol 10, Iss 2, Pp 137-139 (2016)
We describe the case of a young male affected by granulomatosis with polyangiitis presenting with non-specific complaints and complicated by the occurrence of a diffuse endoalveolar hemorrhage characterized by atypical clinical and radiological featu
Externí odkaz:
https://doaj.org/article/092351f85d1646ebb74e451ffa5f5df8
Autor:
Giovanni POMPONIO, Alessia FERRARINI, Diletta OLIVARI, Orazio DE LUCIA, Marco ALBANESE, Maria S. TAJANA, Loris PERTICARINI, Pierfrancesco BETTINSOLI, Arrigo F. CICERO
Publikováno v:
Minerva Orthopedics. 73
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0fc0698cadd39cf0d466ff7e2eea2c77
https://doi.org/10.23736/s2784-8469.22.04240-7
https://doi.org/10.23736/s2784-8469.22.04240-7
Autor:
Alessia Angeletti, Diletta Olivari, Marco B. L. Rocchi, Armando Gabrielli, Giovanni Pomponio, Giulia Rossetti, Vincenzo G Menditto
Publikováno v:
Rheumatology. 60:1640-1650
Objective To analyse the available evidence about the use of rituximab (RTX) and other biologic agents in eosinophilic granulomatosis with polyangiitis (EGPA) patients and to provide useful findings to inform the design of future, reliable clinical t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab93c9edfd4c0231c9ac78a24e2ac165
https://doi.org/10.1093/rheumatology/keab046
https://doi.org/10.1093/rheumatology/keab046
Autor:
Rosa Rita Zortea, Matteo Martinato, Guido Ciprandi, Diletta Olivari, Silvia Marcadelli, Massimo Rivolo, Sara Dionisi, Serena Crucianelli, Armando Gabrielli, Giovanni Pomponio, Fabio Bellini
Publikováno v:
Advances in Wound Care
Significance: A systematic approach to develop experts-based recommendations could have a favorable impact on clinical problems characterized by scarce and low-quality evidence as heel pressure ulcers. Recent Advances: A systematic approach was used
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7b97c697ae2bee78b13df6da1cc76b5
https://doi.org/10.1089/wound.2019.1042
https://doi.org/10.1089/wound.2019.1042
Autor:
Angelica Giuliani, Giulia Matacchione, Deborah Ramini, Mirko Di Rosa, Anna Rita Bonfigli, Jacopo Sabbatinelli, Vladia Monsurrò, Rina Recchioni, Fiorella Marcheselli, Francesca Marchegiani, Francesco Piacenza, Maurizio Cardelli, Roberta Galeazzi, Giovanni Pomponio, Alessia Ferrarini, Armando Gabrielli, Silvia Svegliati Baroni, Marco Moretti, Riccardo Sarzani, Piero Giordano, Antonio Cherubini, Andrea Corsonello, Roberto Antonicelli, Antonio Domenico Procopio, Manuela Ferracin, Massimiliano Bonafè, Fabrizia Lattanzio, Fabiola Olivieri
Publikováno v:
Mechanisms of Ageing and Development
The stratification of mortality risk in COVID-19 patients remains extremely challenging for physicians, especially in older patients. Innovative minimally invasive molecular biomarkers are needed to improve the prediction of mortality risk and better
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b926421fa0395f2149e8406a4d502983
http://hdl.handle.net/11585/858524
http://hdl.handle.net/11585/858524
Autor:
Maria Gabriella Ceravolo, Silvia Tedesco, Maria Mattea Gallo, Michela Coccia, Matteo Andreolini, Oletta Serpilli, Elisa Andrenelli, Claudio Martini, Roberto Papa, Alice Chiarici, Giovanni Pomponio
Publikováno v:
Archives of Physical Medicine and Rehabilitation. 100:1506-1514
To investigate the effectiveness, feasibility, and safety of an evidence-based rehabilitation care pathway in the intensive care unit (ICU) in different patient populations.Observational prospective cohort study, with retrospective controls.ICUs of a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d45e3a8f9c7f7fd0eda2064bbbf4fee
https://doi.org/10.1016/j.apmr.2019.01.015
https://doi.org/10.1016/j.apmr.2019.01.015
Autor:
Francesca Di Nicola, Antonio Di Sario, Laura Bolognini, Emanuele Bendia, Devis Benfaremo, F. Marini, Michele Maria Luchetti, Lucia Perini, Giammarco Fava, Monia Ciferri, Giovanni Pomponio, L. Manfredi, Valentina Marconi, Armando Gabrielli, Antonio Benedetti, Piergiorgio Mosca
Publikováno v:
European Journal of Internal Medicine. 64:76-84
Objective Arthritis is the most frequent extra-intestinal manifestation in patients with inflammatory bowel diseases (IBD). The coexistence of intestinal and articular inflammation advocates the need for a multidisciplinary management of patients wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c38f20471114509f9ab0cff3b36ef9f8
https://doi.org/10.1016/j.ejim.2019.04.015
https://doi.org/10.1016/j.ejim.2019.04.015
Autor:
Marco Moretti, Silvia Baroni, Giovanni Pomponio, Antonio Domenico Procopio, Giulia Matacchione, Fabiola Olivieri, Manuela Ferracin, Marianna Pavani, Massimiliano Bonafè, Noemi Laprovitera, Angelica Giuliani, Alessia Ferrarini, Jacopo Sabbatinelli, Silvia Latini, Armando Gabrielli
Publikováno v:
Mechanisms of Ageing and Development
Highlights • Tocilizumab (TCZ) is currently being tested in COVID‐19‐induced cytokine storm. • COVID-19 patients responding to TCZ have higher post-treatment levels of circulating miR-146a. • Low levels of miR-146a are associated with death
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9b642d64b062ab5ee1f354425d7c4e9
Autor:
Donatella Amico, Federico Mei, Marcello Mario D’Errico, Stefano Menzo, Laura Morbidoni, Marco B. L. Rocchi, Vincenzo G Menditto, Giovanni Pomponio, Marco Moretti, Alessia Ferrarini, Aldo Salvi, Gabriele Frausini, Abele Donati, Silvia Svegliati, Armando Gabrielli, Lina Zuccatosta, Marcello Tavio, Andrea Giacometti, Giancarlo Titolo, Maicol Onesta, Marianna Pavani, Martina Bonifazi
Background: Multiple studies have been conducted to investigate Tocilizumab in patients with cOVID-19 pneumonitis. However, published reports show conflicting results, largely due to weak retrospective designs and heterogeneity in critical methodolog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8c81cdb40468948129ae2b8196d8ca9f
https://doi.org/10.21203/rs.3.rs-42117/v1
https://doi.org/10.21203/rs.3.rs-42117/v1